Good Samaritan Medical Center, INC.

Good Samaritan Medical Center, INC. was paid $13.33M by Medicaid between Jan 2018 and Dec 2024, across 178 billing codes. Its largest line is 99283, emergency room visit (moderate) — 20% of everything it billed.

33Billing provider infoGOOD SAMARITAN MEDICAL CENTER, INC.
WEST PALM BEACH, FL 33401

33aNPI1770515991assigned 07/07/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$13.33M

24GClaims458,669

24DCodes billed178

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Florida

Rank by total paid#39 of 163

Median peer was paid$4.77M

This provider vs. median2.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	38,582	$509K
2019	92,392	$1.44M
2020	79,860	$1.44M
2021	97,590	$2.87M
2022	83,577	$4.30M
2023	44,931	$1.91M
2024incomplete	21,737	$862K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	20%	27,611	24,242	$2.61M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	15%	21,432	17,777	$1.97M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	11%	12,879	10,376	$1.49M
74176	Computed tomography, abdomen and pelvis; without contrast material	6.6%	3,290	2,765	$874K
A4216	Sterile water, saline and/or dextrose, diluent/flush, 10 ml	5.7%	6,326	5,467	$765K
74177	Computed tomography, abdomen and pelvis; with contrast material	4.4%	2,205	1,877	$582K
99282	Emergency department visit for the evaluation and management, low to moderate severity	4.2%	5,898	5,151	$566K
G0378	Hospital observation service, per hour	2.5%	10,783	4,059	$331K
70450	Computed tomography, head or brain; without contrast material	2.4%	4,131	3,269	$322K
96361	Intravenous infusion, hydration; each additional hour	2.3%	6,677	4,741	$303K
80053	Comprehensive metabolic panel	1.8%	20,666	15,821	$238K
71275	Computed tomographic angiography, chest, with contrast material	1.7%	798	678	$223K

166 more codes

Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	1.3%	4,323	$179K
71046	Radiologic examination, chest; 2 views	1.2%	5,786	$160K
76641		<1%	3,752	$129K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	943	$122K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	4,697	$111K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	1,416	$110K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	1,652	$107K
81001		<1%	15,825	$102K
80048	Basic metabolic panel (calcium, ionized)	<1%	8,445	$91K
76536		<1%	1,297	$82K
S0028	Injection, famotidine, 20 mg	<1%	2,499	$71K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	3,674	$67K
A9577	Injection, gadobenate dimeglumine (multihance), per ml	<1%	824	$64K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	1,370	$63K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	864	$59K
76830	Ultrasound, transvaginal	<1%	1,321	$57K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	1,371	$56K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	3,227	$47K
81025		<1%	10,514	$47K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	6,606	$47K
70486		<1%	206	$40K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	1,624	$39K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	319	$37K
77080		<1%	880	$36K
87070		<1%	2,637	$35K
71250		<1%	602	$35K
71045	Radiologic examination, chest; single view	<1%	9,227	$34K
73562		<1%	1,532	$34K
72100		<1%	1,310	$33K
A9270	Non-covered item or service	<1%	6,033	$32K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	29,501	$31K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	2,131	$28K
82962		<1%	6,899	$27K
77066	Tomosynthesis, mammo	<1%	667	$27K
J7050	Infusion, normal saline solution, 250 cc	<1%	4,892	$26K
87400		<1%	2,632	$25K
93971		<1%	1,028	$23K
77063	Screening digital breast tomosynthesis, bilateral	<1%	1,554	$23K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	11,776	$23K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	7,022	$23K
73030		<1%	1,116	$21K
J7030	Infusion, normal saline solution , 1000 cc	<1%	10,975	$21K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	439	$21K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	98	$19K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	1,707	$18K
74018		<1%	619	$18K
77072		<1%	334	$18K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	237	$17K
72125	Computed tomography, cervical spine; without contrast material	<1%	935	$17K
73630		<1%	1,043	$17K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	236	$17K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	10,671	$16K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	954	$16K
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	626	$16K
77065	Tomosynthesis, mammo	<1%	523	$16K
J3490	Unclassified drugs	<1%	151	$15K
93970		<1%	446	$15K
73610		<1%	662	$15K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	2,042	$14K
76770		<1%	270	$14K
72131		<1%	112	$14K
J2704	Injection, propofol, 10 mg	<1%	1,821	$13K
76819	Fetal biophysical profile; without non-stress testing	<1%	118	$12K
96375	Therapeutic injection; each additional sequential IV push	<1%	8,341	$12K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	4,405	$12K
85610		<1%	4,281	$12K
73130		<1%	604	$11K
J1644	Injection, heparin sodium, per 1000 units	<1%	1,409	$10K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	901	$10K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	891	$10K
76775		<1%	169	$10K
72040		<1%	275	$10K
84484		<1%	8,510	$10K
73502		<1%	439	$10K
76801		<1%	740	$10K
36415	Collection of venous blood by venipuncture	<1%	2,212	$9K
84702		<1%	1,927	$9K
85730		<1%	3,728	$9K
85027		<1%	1,060	$8K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	4,855	$7K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	1,366	$7K
83735		<1%	7,953	$6K
J1815	Injection, insulin, per 5 units	<1%	471	$5K
72141		<1%	75	$5K
73110		<1%	286	$5K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	1,708	$5K
96376		<1%	3,254	$5K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	2,145	$4K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	6,450	$4K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	349	$4K
84703		<1%	2,321	$4K
83880		<1%	2,007	$4K
87040		<1%	1,492	$4K
87086	Culture, bacterial; quantitative colony count, urine	<1%	6,133	$4K
86885		<1%	1,572	$4K
83690		<1%	6,083	$3K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	1,368	$3K
82550		<1%	3,937	$3K
J0690	Injection, cefazolin sodium, 500 mg	<1%	644	$3K
86901		<1%	2,437	$3K
80061	Lipid panel	<1%	421	$3K
59025	Fetal non-stress test	<1%	519	$2K
86900		<1%	1,585	$2K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	58	$2K
84443	Thyroid stimulating hormone (TSH)	<1%	1,363	$2K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	483	$2K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	1,239	$2K
87210		<1%	719	$2K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	831	$2K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	859	$2K
87430		<1%	2,716	$1K
99001		<1%	4,774	$1K
87088		<1%	1,371	$1K
83605		<1%	1,160	$1K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	930	$1K
80076		<1%	573	$1K
87186		<1%	1,391	$1K
29125		<1%	65	$975.47
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	339	$936.01
C1769	Guide wire	<1%	20	$903.76
76882		<1%	16	$897.52
84100		<1%	415	$865.00
82150		<1%	1,286	$823.40
85379		<1%	732	$739.87
87420		<1%	492	$719.57
87632		<1%	12	$645.18
97162		<1%	192	$618.93
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	1,334	$606.07
93880		<1%	14	$567.73
83036	Hemoglobin; glycosylated (A1C)	<1%	189	$535.09
76870		<1%	14	$517.10
97161		<1%	54	$445.56
J1170	Injection, hydromorphone, up to 4 mg	<1%	466	$411.86
J2060	Injection, lorazepam, 2 mg	<1%	438	$311.93
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	35	$250.44
88342		<1%	120	$167.15
10060		<1%	44	$154.94
73080		<1%	16	$154.87
J0780	Injection, prochlorperazine, up to 10 mg	<1%	99	$148.68
87077		<1%	882	$121.81
81003		<1%	19	$120.00
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	16	$86.98
73140		<1%	26	$62.20
90715		<1%	220	$61.15
86140		<1%	85	$6.61
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	414	$4.64
J0360	Injection, hydralazine hcl, up to 20 mg	0%	171	$0.00
85651		0%	155	$0.00
A4217	Sterile water/saline, 500 ml	0%	78	$0.00
J2360	Injection, orphenadrine citrate, up to 60 mg	0%	59	$0.00
J0330	Injection, succinylcholine chloride, up to 20 mg	0%	46	$0.00
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	0%	15	$0.00
S0020	Injection, bupivicaine hydrochloride, 30 ml	0%	36	$0.00
88307		0%	15	$0.00
J2370	Injection, phenylephrine hcl, up to 1 ml	0%	38	$0.00
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	0%	18	$0.00
74022		0%	15	$0.00
J3475	Injection, magnesium sulfate, per 500 mg	0%	72	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	18	$0.00
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	0%	14	$0.00
97116		0%	30	$0.00
99218		0%	106	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	18	$0.00
94664		0%	162	$0.00
82947		0%	15	$0.00
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	0%	35	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGUITTAP, TAYLOR (CFO)